Imipenem/Cilastatin versus Cefepime as Empiric Monotherapy for Fever in Neutropenic Patients after ematopoietic Stem Cell Transplantation

Objective: To evaluate the potential advantages of imipenem/cilastatin in control of fever in neutro-penic HSCT recipients.Patients and Method: In this single-center study, 111 consecutive febrile episodes in 104 neutropenic HSCT recipients with a mean age of 26 years were randomized to treatment ei...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: C Kani, A Mousavi, M Iravani, K Alimoghaddam, B Bahar, M Jahani, A Ghavamzadeh
Formato: Artigo
Idioma:Inglês
Publicado em: Tehran University of Medical Sciences 2005-06-01
Colecção:International Journal of Hematology-Oncology and Stem Cell Research
Assuntos:
Febrile neutropenia
Monotherapy Hematopoietic
stem cell transplantation
Randomized trial
Acesso em linha:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/189
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados